<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kang D</submitter><funding>NCATS NIH HHS</funding><funding>NIH HHS</funding><pagination>504</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10408090</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To compare hospitals that did and did not participate in clinical trials evaluating potential inpatient COVID-19 therapeutics.&lt;h4>Methods&lt;/h4>We conducted a cross-sectional study of hospitals participating in trials that were registered on clinicaltrials.gov between April and August 2020. Using the 2019 RAND Hospital Dataset and 2019 American Community Survey, we used logistic regression modeling to compare hospital-level traits including demographic features between trial and non-trial hospitals.&lt;h4>Results&lt;/h4>We included 488 hospitals that were participating in 298 interventional trials and 4232 non-participating hospitals. After controlling for demographic and other hospital traits, we found that teaching status (OR 2.11, 95% CI 1.52-2.95), higher patient acuity (OR </pubmed_abstract><journal>Trials</journal><pubmed_title>Do hospitals that participate in COVID-19 research differ from non-trial hospitals? A cross-sectional study of US hospitals.</pubmed_title><pmcid>PMC10408090</pmcid><funding_grant_id>P30AG021684</funding_grant_id><funding_grant_id>UL1 TR001881</funding_grant_id><funding_grant_id>ULL1TR001881</funding_grant_id><pubmed_authors>Kang D</pubmed_authors><pubmed_authors>Huang CX</pubmed_authors><pubmed_authors>Norris KC</pubmed_authors><pubmed_authors>Vijayan T</pubmed_authors><pubmed_authors>Yuen AD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Do hospitals that participate in COVID-19 research differ from non-trial hospitals? A cross-sectional study of US hospitals.</name><description>&lt;h4>Objectives&lt;/h4>To compare hospitals that did and did not participate in clinical trials evaluating potential inpatient COVID-19 therapeutics.&lt;h4>Methods&lt;/h4>We conducted a cross-sectional study of hospitals participating in trials that were registered on clinicaltrials.gov between April and August 2020. Using the 2019 RAND Hospital Dataset and 2019 American Community Survey, we used logistic regression modeling to compare hospital-level traits including demographic features between trial and non-trial hospitals.&lt;h4>Results&lt;/h4>We included 488 hospitals that were participating in 298 interventional trials and 4232 non-participating hospitals. After controlling for demographic and other hospital traits, we found that teaching status (OR 2.11, 95% CI 1.52-2.95), higher patient acuity (OR </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-04-04T03:06:35.099Z</modification><creation>2024-12-04T03:20:18.204Z</creation></dates><accession>S-EPMC10408090</accession><cross_references><pubmed>37550662</pubmed><doi>10.1186/s13063-023-07450-6</doi></cross_references></HashMap>